RCM
ABMD

Rotella Capital Management’s Abiomed Inc ABMD Stock Holding History

Rotella Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,049
Closed -$200K – 690
2015
Q2 		$200K Buy
+3,049
New +$203K 0.16% 173

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rotella Capital Management's ABMD Position: Q3 2015 in Review

Rotella Capital Management sold out of Abiomed Inc (ABMD) in Q3 2015, closing a stake of 3,049 shares — an estimated $200K sold.

Rotella Capital Management first reported a position in ABMD in Q2 2015 and held it in 1 quarter. The position peaked at $200K in Q2 2015. 243 funds tracked by Wall St. Rank hold ABMD as of Q3 2015.

  • Rotella Capital Management reported no remaining Abiomed Inc position as of Q3 2015 after selling out during the quarter.
  • Rotella Capital Management sold 3,049 Abiomed Inc shares in Q3 2015, an estimated $200K.
  • Rotella Capital Management first reported a position in Abiomed Inc in Q2 2015 and held it in 1 quarter.
  • Rotella Capital Management's Abiomed Inc position peaked at $200K in Q2 2015.
  • 243 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.